FDA Approves Ganaxolone for Seizure Treatment in Children Over 2, DEA Places in Schedule V

Summary

The US FDA approved ganaxolone for treating seizures in children over 2 years old, and the DEA has placed it in Schedule V of the Controlled Substances Act, following a recommendation from the Department of Health and Human Services.